相关实验视频

Updated: Jul 4, 2025

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Published on: September 6, 2024

作为神经退行症治疗发展模型的iPSC衍生微质的转录性表征

Gokul Ramaswami¹, Yeliz Yuva-Aydemir², Brynn Akerberg²

¹CAMP4 Therapeutics Corporation, Cambridge, MA, USA. gokul@camp4tx.com.

Scientific reports

|January 25, 2024

概括

人类诱导的多能干细胞衍生微状细胞 (iMGL) 密切模仿初级微. 这些iMGL细胞表现出复杂的转录特征和响应能力,使它们成为神经退行性疾病研究的有希望的模型.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
干细胞生物学干细胞生物学

背景情况:

微质细胞,大脑的免疫细胞,在神经炎症和神经退行性疾病中至关重要.
诱导性微状细胞 (iMGL) 提供了一个体外模型,但需要对初级人类微进行验证.
缺乏对iMGL相似性和对外部刺激的反应能力的系统评估.

研究的目的:

为了通过转录来表征人类iPSC衍生的微状细胞 (iMGL) 细胞.
评估iMGL细胞与人类初级微质细胞的相似性.
评估iMGL对肝X受体 (LXR) 通路激动剂的反应能力.

主要方法:

批量和单细胞IMGL细胞的RNA测序.
在接受LXR激动剂治疗之前和之后,对iMGL细胞进行转录分析.
将iMGL转录组与人类初级微质细胞进行比较.

主要成果:

大量转录组分析显示,iMGL细胞与主要微质细胞共享表达特征,包括关键的转录因子和与疾病相关的基因.
单细胞分析确定了不同的iMGL亚群,反映了原发性微质细胞中发现的恒常状态和激活状态.
治疗LXR激动剂诱导了IMGL细胞中脂质代谢和细胞周期的显著转录变化,在亚群中产生异质反应.

结论:

人类iMGL细胞表现出复杂的转录特征和响应能力,与体内微相比较.
这些细胞代表了一个有价值的体外模型系统,用于研究神经炎症和开发神经退行性疾病的治疗方法.
单细胞分析为iMGL反应的异质性提供了关键的见解.

更多相关视频

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...